Endothelial vasomotor dysfunction in the brachial artery predicts the short-term development of early stage renal dysfunction in patients with coronary artery disease.

[1]  A. Coats,et al.  Ethical authorship and publishing. , 2009, International journal of cardiology.

[2]  S. Yusuf,et al.  Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial , 2008, The Lancet.

[3]  J. Mehta,et al.  Effect of statins on the development of renal dysfunction. , 2008, The American journal of cardiology.

[4]  S. Buscemi,et al.  Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. , 2008, Journal of nephrology.

[5]  C. Zoccali.  The endothelium as a target in renal diseases. , 2007, Journal of nephrology.

[6]  E. Schiffrin,et al.  Chronic Kidney Disease: Effects on the Cardiovascular System , 2007, Circulation.

[7]  T. Rabelink,et al.  Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.

[8]  B. Brenner,et al.  Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. , 2006, Kidney international.

[9]  R. Henning,et al.  Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response. , 2006, Journal of nephrology.

[10]  R. Henning,et al.  Endothelial function predicts the development of renal damage after combined nephrectomy and myocardial infarction. , 2006, Journal of the American Society of Nephrology : JASN.

[11]  P. van der Harst,et al.  Vascular Function and Mild Renal Impairment in Stable Coronary Artery Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[12]  Takamitsu Nakamura,et al.  Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. , 2005, Atherosclerosis.

[13]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[14]  R. Gupta,et al.  The renal patient with coronary artery disease: current concepts and dilemmas. , 2004, Journal of the American College of Cardiology.

[15]  C. Zoccali,et al.  Endothelial Dysfunction and Mild Renal Insufficiency in Essential Hypertension , 2004, Circulation.

[16]  J. Morrow,et al.  Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. , 2004, Kidney international.

[17]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[18]  L. Truong,et al.  Role of the microvascular endothelium in progressive renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[19]  A. Mimran,et al.  Nitric Oxide Inhibition and Renal Alterations , 2001, Journal of cardiovascular pharmacology.

[20]  M. Labeeuw,et al.  Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment. , 1999, Kidney international.

[21]  K. Kugiyama,et al.  Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels. , 1999, Journal of the American College of Cardiology.

[22]  A. Yeung,et al.  Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.

[23]  R. Zatz,et al.  Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. , 1994, The American journal of physiology.

[24]  N. Madias,et al.  Serum creatinine as an index of renal function: new insights into old concepts. , 1992, Clinical chemistry.

[25]  B. Brenner,et al.  Endothelium-derived vasoactive factors and the renal vasculature. , 1991, The American journal of physiology.

[26]  K. Borch-Johnsen,et al.  Albuminuria reflects widespread vascular damage , 1989, Diabetologia.

[27]  L. Bouter,et al.  Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. , 2006, Journal of the American Society of Nephrology : JASN.

[28]  Gian Paolo Rossi,et al.  Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. , 2005, Journal of hypertension.